Tekla Life Sciences Investors Stock Price and Value Analysis

Should you buy Tekla Life Sciences Investors stock? (NYSE:HQL). Let's see how it does in our automated value investing analysis system.

Key Facts

  • Ticker: HQL (NYSE)
  • Current price: $19.25
  • Sector: Unknown
  • Industry: Unknown
  • Dividend yield:

Advertisement helps keep Trendshare free for most readers.

Hold-time calculator

Estimate how long you need to hold Tekla Life Sciences Investors to reach your target.

Target type
AdvantagesDisadvantages
  • This company has amazingly consistent growth!
  • This company has a large dividend yield!
  • This company is less known than others.
  • This company is not making money.
  • This stock looks overpriced.

Inside the HQL Numbers

HQL Price
(Tekla Life Sciences Investors stock price per share)
$19.25
[?] PE Ratio versus Sector 78% lower than other Unknown stocks
[?] PE Ratio versus Industry 83% lower than other Unknown stocks
[?] Free Cash Flow Jitter 0%
[?] Dividend Yield 10% (tax impact)
Shares Shorted 14,265

Related guides: good annual rate of return · high-yield stocks · forecasting earnings growth

Is Tekla Life Sciences Investors Stock on Sale?

Based on our analysis, we believe that you should not buy Tekla Life Sciences Investors right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Advertisement supports free stock analysis content.

Should You Buy HQL Stock?

Does Tekla Life Sciences Investors have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.

We don't yet have enough financial history for Tekla Life Sciences Investors to produce a full worked example. Check back as more data becomes available, or see the current price and research links below.